Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease

DNA damage can cause (and result from) oxidative stress and mitochondrial impairment, both of which are implicated in the pathogenesis of Parkinson's disease (PD). We therefore examined the role of mitochondrial DNA (mtDNA) damage in human postmortem brain tissue and in in vivo and in vitro mod...

Full description

Bibliographic Details
Main Authors: Laurie H. Sanders, Jennifer McCoy, Xiaoping Hu, Pier G. Mastroberardino, Bryan C. Dickinson, Christopher J. Chang, Charleen T. Chu, Bennett Van Houten, J.T. Greenamyre
Format: Article
Language:English
Published: Elsevier 2014-10-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996114001788
id doaj-a3e0fb76bd764bb882e1a79cace17569
record_format Article
spelling doaj-a3e0fb76bd764bb882e1a79cace175692021-03-22T12:41:34ZengElsevierNeurobiology of Disease1095-953X2014-10-0170214223Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's diseaseLaurie H. Sanders0Jennifer McCoy1Xiaoping Hu2Pier G. Mastroberardino3Bryan C. Dickinson4Christopher J. Chang5Charleen T. Chu6Bennett Van Houten7J.T. Greenamyre8Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USAPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USAPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USADepartment of Genetics, Erasmus MC, Rotterdam, The NetherlandsDepartment of Chemistry, University of California, Berkeley, CA 94720, USADepartment of Chemistry, University of California, Berkeley, CA 94720, USA; Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USADepartment of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USADepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; The University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA 15213, USAPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USA; Corresponding author at: University of Pittsburgh, 3501 Fifth Avenue, Suite 7039, Pittsburgh, PA 15260, USA. Fax: +1 412 648 9766.DNA damage can cause (and result from) oxidative stress and mitochondrial impairment, both of which are implicated in the pathogenesis of Parkinson's disease (PD). We therefore examined the role of mitochondrial DNA (mtDNA) damage in human postmortem brain tissue and in in vivo and in vitro models of PD, using a newly adapted histochemical assay for abasic sites and a quantitative polymerase chain reaction (QPCR)-based assay. We identified the molecular identity of mtDNA damage to be apurinic/apyrimidinic (abasic) sites in substantia nigra dopamine neurons, but not in cortical neurons from postmortem PD specimens. To model the systemic mitochondrial impairment of PD, rats were exposed to the pesticide rotenone. After rotenone treatment that does not cause neurodegeneration, abasic sites were visualized in nigral neurons, but not in cortex. Using a QPCR-based assay, a single rotenone dose induced mtDNA damage in midbrain neurons, but not in cortical neurons; similar results were obtained in vitro in cultured neurons. Importantly, these results indicate that mtDNA damage is detectable prior to any signs of degeneration — and is produced selectively in midbrain neurons under conditions of mitochondrial impairment. The selective vulnerability of midbrain neurons to mtDNA damage was not due to differential effects of rotenone on complex I since rotenone suppressed respiration equally in midbrain and cortical neurons. However, in response to complex I inhibition, midbrain neurons produced more mitochondrial H2O2 than cortical neurons. We report selective mtDNA damage as a molecular marker of vulnerable nigral neurons in PD and suggest that this may result from intrinsic differences in how these neurons respond to complex I defects. Further, the persistence of abasic sites suggests an ineffective base excision repair response in PD.http://www.sciencedirect.com/science/article/pii/S0969996114001788Parkinson's diseaseMitochondrial DNA damageAbasic sites
collection DOAJ
language English
format Article
sources DOAJ
author Laurie H. Sanders
Jennifer McCoy
Xiaoping Hu
Pier G. Mastroberardino
Bryan C. Dickinson
Christopher J. Chang
Charleen T. Chu
Bennett Van Houten
J.T. Greenamyre
spellingShingle Laurie H. Sanders
Jennifer McCoy
Xiaoping Hu
Pier G. Mastroberardino
Bryan C. Dickinson
Christopher J. Chang
Charleen T. Chu
Bennett Van Houten
J.T. Greenamyre
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
Neurobiology of Disease
Parkinson's disease
Mitochondrial DNA damage
Abasic sites
author_facet Laurie H. Sanders
Jennifer McCoy
Xiaoping Hu
Pier G. Mastroberardino
Bryan C. Dickinson
Christopher J. Chang
Charleen T. Chu
Bennett Van Houten
J.T. Greenamyre
author_sort Laurie H. Sanders
title Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
title_short Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
title_full Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
title_fullStr Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
title_full_unstemmed Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
title_sort mitochondrial dna damage: molecular marker of vulnerable nigral neurons in parkinson's disease
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2014-10-01
description DNA damage can cause (and result from) oxidative stress and mitochondrial impairment, both of which are implicated in the pathogenesis of Parkinson's disease (PD). We therefore examined the role of mitochondrial DNA (mtDNA) damage in human postmortem brain tissue and in in vivo and in vitro models of PD, using a newly adapted histochemical assay for abasic sites and a quantitative polymerase chain reaction (QPCR)-based assay. We identified the molecular identity of mtDNA damage to be apurinic/apyrimidinic (abasic) sites in substantia nigra dopamine neurons, but not in cortical neurons from postmortem PD specimens. To model the systemic mitochondrial impairment of PD, rats were exposed to the pesticide rotenone. After rotenone treatment that does not cause neurodegeneration, abasic sites were visualized in nigral neurons, but not in cortex. Using a QPCR-based assay, a single rotenone dose induced mtDNA damage in midbrain neurons, but not in cortical neurons; similar results were obtained in vitro in cultured neurons. Importantly, these results indicate that mtDNA damage is detectable prior to any signs of degeneration — and is produced selectively in midbrain neurons under conditions of mitochondrial impairment. The selective vulnerability of midbrain neurons to mtDNA damage was not due to differential effects of rotenone on complex I since rotenone suppressed respiration equally in midbrain and cortical neurons. However, in response to complex I inhibition, midbrain neurons produced more mitochondrial H2O2 than cortical neurons. We report selective mtDNA damage as a molecular marker of vulnerable nigral neurons in PD and suggest that this may result from intrinsic differences in how these neurons respond to complex I defects. Further, the persistence of abasic sites suggests an ineffective base excision repair response in PD.
topic Parkinson's disease
Mitochondrial DNA damage
Abasic sites
url http://www.sciencedirect.com/science/article/pii/S0969996114001788
work_keys_str_mv AT lauriehsanders mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT jennifermccoy mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT xiaopinghu mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT piergmastroberardino mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT bryancdickinson mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT christopherjchang mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT charleentchu mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT bennettvanhouten mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
AT jtgreenamyre mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease
_version_ 1724208267152850944